IMMUNOHISTOCHEMISTRY, 34-BETA E12

The IHC – 34 Beta E12 test is a specialized immunohistochemistry (IHC) diagnostic test used to detect high molecular weight cytokeratin (HMWCK) expression in tissue samples. The 34 Beta E12 antibody identifies specific cytokeratin proteins present in basal epithelial cells and is widely used in pathology for diagnosing and classifying epithelial tumors.

This marker is especially important in prostate pathology, where it helps distinguish benign prostate glands from prostate adenocarcinoma. Normal prostate tissue contains basal cells that stain positive with 34 Beta E12, while most prostate adenocarcinomas lack basal cell staining. This makes the test highly valuable for confirming suspicious prostate lesions.

The test is also useful in evaluating urothelial tumors, squamous lesions, breast pathology, and other epithelial neoplasms, where cytokeratin expression patterns help classify tissue origin and identify abnormal cell differentiation.

The IHC 34 Beta E12 test is often performed along with markers such as p63, AMACR (P504S), CK5/6, PSA, and PIN4 for improved diagnostic accuracy.

Benefits of the Test

The 34 Beta E12 test offers several important clinical benefits:

• Detects high molecular weight cytokeratin expression
• Identifies basal epithelial cells accurately
• Helps distinguish benign and malignant prostate lesions
• Supports epithelial tumor classification
• Assists in difficult pathology diagnosis
• Improves diagnostic confidence

This test is essential for accurate epithelial tissue evaluation.

Why Doctors Recommend This Test

Doctors recommend the 34 Beta E12 test when epithelial lesion classification or prostate cancer diagnosis requires confirmation.

It is commonly advised for:

• Suspicious prostate biopsy evaluation
• Differentiation of benign and malignant prostate lesions
• Urothelial tumor analysis
• Epithelial tumor classification
• Complex pathology confirmation cases

The results help pathologists make accurate diagnoses and guide effective treatment planning.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected tissue biopsy or surgical specimens.

Normal Reporting Time

The usual turnaround time for the 34 Beta E12 IHC test is 2 to 5 working days, depending on tissue complexity and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients undergoing prostate biopsy evaluation
• Individuals with suspected prostate cancer
• Patients with epithelial tissue abnormalities
• Cases requiring basal cell identification
• Oncology patients needing accurate tissue diagnosis

The IHC 34 Beta E12 test is an important diagnostic tool in pathology. It helps identify basal epithelial cells, supports accurate tumor classification, and improves diagnostic precision for better patient care.